Nov 16 (Reuters) - Mesoblast Ltd MSB.AX :
* Mesoblast lists on NASDAQ MSB.AX
* Says intends to use the net proceeds of this offering for ongoing clinical programs
* Says expects to receive gross proceeds of A$95.8 million , before deduction of underwriting discounts and commissions and expenses
* Source text for Eikon ID:nASX3WlRfH